What is the recommended treatment for Trichomonas vaginalis in partners?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomonas vaginalis in Partners

Sex partners of patients with Trichomonas vaginalis infection should be treated simultaneously with metronidazole 2g orally in a single dose to prevent reinfection. 1, 2

First-Line Treatment Options for Partners

  • Metronidazole 2g orally in a single dose is the recommended first-line treatment for partners, with cure rates of approximately 90-95% 1, 2
  • An alternative regimen is metronidazole 500mg orally twice daily for 7 days, which may be considered when medication adherence is not a concern 2
  • Tinidazole 2g as a single oral dose is an FDA-approved alternative, particularly useful in cases where metronidazole treatment has failed 3

Importance of Partner Treatment

  • Treatment of both the patient and sex partners results in relief of symptoms, microbiologic cure, and reduction of transmission 4
  • Since trichomoniasis is a sexually transmitted disease, treating partners simultaneously is essential to prevent reinfection 2, 3
  • Failure to treat sexual partners significantly increases the risk of reinfection 5

Post-Treatment Recommendations

  • Patients should be instructed to avoid sex until both they and their partner(s) are cured 4, 2
  • In the absence of microbiologic test-of-cure, this means when therapy has been completed and both patient and partner(s) are asymptomatic 4
  • Routine follow-up is unnecessary for men who become asymptomatic after treatment 1, 2

Management of Treatment Failure

  • If treatment fails with either regimen, retreat with metronidazole 500mg twice daily for 7 days 4, 2
  • For repeated failure, administer metronidazole 2g once daily for 3-5 days 4, 5
  • If treatment continues to fail and reinfection has been excluded, consider tinidazole as an alternative treatment option 6
  • Consultation with an infectious disease specialist is recommended for persistent infections 5

Important Clinical Considerations

  • Metronidazole gel is NOT effective for trichomoniasis (efficacy <50%) and should not be used 1, 2
  • Patients should avoid alcohol during treatment with metronidazole and for at least 24 hours after completing therapy due to potential disulfiram-like reactions 1
  • For tinidazole, alcoholic beverages should be avoided during treatment and for 3 days afterward 3

Special Situations

  • For partners with HIV infection, the same treatment regimen applies as for HIV-negative individuals 2, 5
  • For partners with true metronidazole allergy, desensitization may be required as effective alternatives are limited 4, 2
  • Tinidazole may be considered for patients who fail metronidazole therapy, as suggested by recent research showing effectiveness in metronidazole-resistant cases 6

Michigan-Specific Considerations

  • Michigan follows the CDC guidelines for treatment of trichomoniasis in partners
  • The same treatment regimens and partner management strategies apply throughout the state
  • Expedited partner therapy may be considered to ensure partners receive treatment, especially when partners are unlikely to seek medical care 7

References

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomonas vaginalis Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Trichomonas Vaginalis Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.